CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...
CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...
Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...
The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results fr...
AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that&n...
CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I ...
Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...
DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...
US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...
CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...
